B

Biolight Life Sciences Ltd
TASE:BOLT

Watchlist Manager
Biolight Life Sciences Ltd
TASE:BOLT
Watchlist
Price: 625 ILS 1.41% Market Closed
Market Cap: 27.4m ILS
Have any thoughts about
Biolight Life Sciences Ltd?
Write Note

Operating Margin
Biolight Life Sciences Ltd

-5 026.3%
Current
-79 133.5%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5 026.3%
=
Operating Profit
-10m
/
Revenue
198k

Operating Margin Across Competitors

Country IL
Market Cap 27.4m ILS
Operating Margin
-5 026%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 201.7B USD
Operating Margin
17%
Country US
Market Cap 173.6B USD
Operating Margin
21%
Country KR
Market Cap 67.8T KRW
Operating Margin
31%
Country CH
Market Cap 38.6B CHF
Operating Margin
13%
Country US
Market Cap 39.6B USD
Operating Margin
25%
Country US
Market Cap 36.8B USD
Operating Margin
14%
Country US
Market Cap 26.9B USD
Operating Margin
28%
Country US
Market Cap 23.5B USD
Operating Margin
20%
Country US
Market Cap 23.2B USD
Operating Margin
29%
No Stocks Found

Biolight Life Sciences Ltd
Glance View

Market Cap
27.4m ILS
Industry
Life Sciences Tools & Services

BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.

BOLT Intrinsic Value
27.24 ILS
Overvaluation 96%
Intrinsic Value
Price
B

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5 026.3%
=
Operating Profit
-10m
/
Revenue
198k
What is the Operating Margin of Biolight Life Sciences Ltd?

Based on Biolight Life Sciences Ltd's most recent financial statements, the company has Operating Margin of -5 026.3%.